NCT02965703 2026-04-13
Aspirin in Preventing Colorectal Cancer in Patients With Colorectal Adenoma
National Cancer Institute (NCI)
Phase 2 Active not recruiting
Clinical Trials
50 trialsNCT05557877 2026-03-31
Low Dose Aspirin for the Prevention of Postpartum Related Breast Cancer
Mayo Clinic
Phase 2 Recruiting
NCT03654105 2026-03-27
SMILE
Fondazione IRCCS Istituto Nazionale dei Tumori, Milano
Phase 2 Active not recruiting
NCT06728072 2026-02-09
Addition of Antibiotics to Upfront Treatment Regimen for Colorectal Cancer
Virginia Commonwealth University
Phase 2 Recruiting
NCT04184921 2026-02-03
Combination of Osimertinib and Aspirin to Treat EGFR Mutation NSCLC Patients
Daping Hospital and the Research Institute of Surgery of the Third Military Medical University
Phase 2 Completed
NCT06866964 2026-02-02
ASPIRE
Wake Forest University Health Sciences
Phase 2 Recruiting
NCT03480776 2026-01-14
ASA in Prevention of Ovarian Cancer (STICs and STONEs)
Canadian Cancer Trials Group
Phase 2 Active not recruiting
NCT03079999 2025-12-18
Study of Aspirin in Patients With Vestibular Schwannoma
Massachusetts Eye and Ear Infirmary
Phase 2 Active not recruiting
NCT04188119 2025-12-08
IMpALA
The Christie NHS Foundation Trust
Phase 2 Withdrawn
NCT05411718 2025-11-13
A Phase IIa Randomized, Double-Blinded Clinical Trial of Naproxen or Aspirin for Cancer Immune Interception in Lynch Syndrome
M.D. Anderson Cancer Center
Phase 2 Recruiting
NCT02521285 2025-10-23
Aspirin in Preventing Disease Recurrence in Patients With Barrett Esophagus After Successful Elimination by Radiofrequency Ablation
National Cancer Institute (NCI)
Phase 2 Active not recruiting
NCT04182100 2025-09-15
Efficacy and Safety of P1101 in Polycythemia Vera Patients for Whom the Standard of Treatment is Difficult to Apply
PharmaEssentia Japan K.K.
Phase 2 Completed
NCT03899987 2025-08-27
Aspirin and Rintatolimod With or Without Interferon-alpha 2b in Treating Patients With Prostate Cancer Before Surgery
Roswell Park Cancer Institute
Phase 2 Active not recruiting
NCT03543683 2025-02-27
Combination of Osimertinib and Aspirin to Treat 1st Generation EGFR-TKI Resistance in NSCLC
Daping Hospital and the Research Institute of Surgery of the Third Military Medical University
Phase 2 Completed
NCT03957902 2025-02-27
Assessment of Direct Biomarkers of Aspirin Action to Develop a Precision Chemoprevention Therapy of Colorectal Cancer
Instituto de Investigación Sanitaria Aragón
Phase 2 Recruiting
NCT04160546 2024-12-31
ResToP
Fundacion CRIS de Investigación para Vencer el Cáncer
Phase 2 Active not recruiting
NCT04534218 2024-12-20
REPROGRAM-01
Centre Hospitalier Universitaire de Besancon
Phase 2 Completed
NCT00482261 2024-11-08
A Study of Low Dose Lenalidomide and Dexamethasone in Relapsed/Refractory Myeloma in Patients at High Risk for Myelosuppression
Peter MacCallum Cancer Centre, Australia
Phase 2 Completed
NCT03003325 2024-09-19
Low-PV
FROM- Fondazione per la Ricerca Ospedale di Bergamo- ETS
Phase 2 Completed
NCT04243122 2024-05-29
AIRPORT-MPN
Ottawa Hospital Research Institute
Phase 2 Completed
NCT05637567 2023-11-13
ASAP
German Cancer Research Center
Phase 2 Not yet recruiting
NCT06018688 2023-09-21
Osimertinib Combined With Aspirin Neoadjuvant Therapy for Resectable EGFR Mutated NSCLC Patients.
Daping Hospital and the Research Institute of Surgery of the Third Military Medical University
Phase 2 Not yet recruiting
NCT00578721 2023-07-07
Trial of Aspirin and Arginine Restriction in Colorectal Cancer
University of California, Irvine
Phase 2 Completed
NCT02659384 2023-03-14
Anti-programmed Cell Death-1 Ligand 1 (aPDL-1) Antibody Atezolizumab, Bevacizumab and Acetylsalicylic Acid in Recurrent Platinum Resistant Ovarian Cancer
European Organisation for Research and Treatment of Cancer - EORTC
Phase 2 Completed
NCT02420652 2023-02-08
PRIMA
Rutgers, The State University of New Jersey
Phase 2 Terminated
NCT03396952 2022-10-13
Prostaglandin Inhibition and Immune Checkpoint Blockade in Melanoma
University of California, San Francisco
Phase 2 Completed
NCT05402124 2022-06-02
The Colorectal Cancer Chemoprevention Acceleration and Improvement Platform (CRC-CHAMP) Study
University of Calgary
Phase 2 Unknown
NCT04062032 2022-02-18
Metabolomic and Inflammatory Effects of Oral Aspirin (ASA) in Subjects at Risk for Melanoma
University of Utah
Phase 2 Completed
NCT04066725 2022-02-18
Aspirin as an Ultraviolet (UV) Protectant in Human Subjects at Risk for Melanoma
University of Utah
Phase 2 Completed
NCT04038489 2021-11-22
Breast 51
University of Virginia
Phase 2 Withdrawn
NCT03192059 2021-09-08
PRIMMO
University Hospital, Ghent
Phase 2 Completed
NCT03170115 2020-12-17
ICAR
Instituto Nacional de Cancer, Brazil
Phase 2 Terminated
NCT03356769 2020-06-09
Aspirin as an add-on Treatment of Refractory Epilepsy in Tuberous Sclerosis Complex
Peking Union Medical College Hospital
Phase 2 Unknown
NCT02169271 2020-05-21
Acetylsalicylic Acid Compared to Placebo in Treating High-Risk Patients With Subsolid Lung Nodules
National Cancer Institute (NCI)
Phase 2 Completed
NCT00983580 2019-09-04
Acetylsalicylic Acid and Eflornithine in Treating Patients at High Risk for Colorectal Cancer
National Cancer Institute (NCI)
Phase 2 Completed
NCT03794596 2019-07-22
IMpALA
The Christie NHS Foundation Trust
Phase 2 Withdrawn
NCT02123849 2018-08-29
Intermittent or Continuous Acetylsalicylic Acid and Gene Expression in the Nasal Tissue of Current Smokers
National Cancer Institute (NCI)
Phase 2 Completed
NCT03290820 2017-10-26
Aspirin Improve Survival of N2-3 Nasopharyngeal Carcinoma Patients
Sun Yat-sen University
Phase 2 Unknown
NCT00468910 2017-05-31
Aspirin in Preventing Colorectal Cancer in Patients at Increased Risk of Colorectal Cancer
National Cancer Institute (NCI)
Phase 2 Completed
NCT00263211 2017-03-15
A Study of the Effects of Inhibiting Platelet Function on Circulating Cancer Cells in Breast Cancer Patients
Washington University School of Medicine
Phase 2 Terminated
NCT01259817 2017-01-11
Pegylated Interferon Alfa-2a Salvage Therapy in High Risk Polycythemia Vera (PV) or Essential Thrombocythemia (ET)
Icahn School of Medicine at Mount Sinai
Phase 2 Completed
NCT02323516 2015-12-08
ASPIDIA
Centre Francois Baclesse
Phase 2 Withdrawn
NCT02602938 2015-11-13
ACABC
Zhejiang Provincial People's Hospital
Phase 2 Unknown
NCT00940784 2014-11-26
ISCLAP
Icahn School of Medicine at Mount Sinai
Phase 2 Withdrawn
NCT00691704 2014-08-19
Celgene High Risk Multiple Myeloma (MM) Revlimid Induction and Maintenance Therapy
Duke University
Phase 2 Completed
NCT00474903 2014-07-02
Esomeprazole Magnesium With or Without Aspirin in Preventing Esophageal Cancer in Patients With Barrett Esophagus
National Cancer Institute (NCI)
Phase 2 Completed
NCT00020189 2013-06-19
Flavopiridol in Treating Patients With Recurrent or Metastatic Head and Neck Cancer
National Cancer Institute (NCI)
Phase 2 Completed
NCT01431053 2013-03-13
Study of Aspirin and Exemestane as Adjuvant Treatment in Breast Cancer
ChineseAMS
Phase 2 Unknown
NCT00062023 2012-07-30
Comparison of Sulindac, Aspirin, and Ursodiol in Preventing Colorectal Cancer
M.D. Anderson Cancer Center
Phase 2 Terminated
NCT00790452 2011-12-08
Aspirin Prophylaxis for Venous Thromboembolism in Glioblastoma
M.D. Anderson Cancer Center
Phase 2 Terminated